These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11865401)

  • 1. Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a.
    Johnson SE; Dykes JK; Jue DL; Sampson JS; Carlone GM; Ades EW
    J Infect Dis; 2002 Feb; 185(4):489-96. PubMed ID: 11865401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?
    Rapola S; Kilpi T; Lahdenkari M; Takala AK; Mäkelä PH; Käyhty H
    J Infect Dis; 2001 Sep; 184(5):577-81. PubMed ID: 11494164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
    Rapola S; Jäntti V; Haikala R; Syrjänen R; Carlone GM; Sampson JS; Briles DE; Paton JC; Takala AK; Kilpi TM; Käyhty H
    J Infect Dis; 2000 Oct; 182(4):1146-52. PubMed ID: 10979911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage.
    Holmlund E; Quiambao B; Ollgren J; Nohynek H; Käyhty H
    Vaccine; 2006 Jan; 24(1):57-65. PubMed ID: 16115703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
    Simell B; Korkeila M; Pursiainen H; Kilpi TM; Käyhty H
    J Infect Dis; 2001 Mar; 183(6):887-96. PubMed ID: 11237805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.
    Whaley MJ; Sampson JS; Johnson SE; Rajam G; Stinson-Parks A; Holder P; Mauro E; Romero-Steiner S; Carlone GM; Ades EW
    Vaccine; 2010 Apr; 28(18):3071-5. PubMed ID: 20206671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).
    Talkington DF; Brown BG; Tharpe JA; Koenig A; Russell H
    Microb Pathog; 1996 Jul; 21(1):17-22. PubMed ID: 8827703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
    Shah P; Briles DE; King J; Hale Y; Swiatlo E
    Exp Biol Med (Maywood); 2009 Apr; 234(4):403-9. PubMed ID: 19176871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library.
    Srivastava N; Zeiler JL; Smithson SL; Carlone GM; Ades EW; Sampson JS; Johnson SE; Kieber-Emmons T; Westerink MA
    Hybridoma; 2000 Feb; 19(1):23-31. PubMed ID: 10768838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
    Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
    Laval CB; de Andrade AL; Pimenta FC; de Andrade JG; de Oliveira RM; Silva SA; de Lima EC; Fabio JL; Casagrande ST; Brandileone MC
    Clin Microbiol Infect; 2006 Jan; 12(1):50-5. PubMed ID: 16460546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J; Cui YL; Jiang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
    Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
    J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease.
    Baril L; Briles DE; Crozier P; King J; Punar M; Hollingshead SK; McCormick JB
    Vaccine; 2004 Dec; 23(6):789-93. PubMed ID: 15542203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies.
    Romero-Steiner S; Caba J; Rajam G; Langley T; Floyd A; Johnson SE; Sampson JS; Carlone GM; Ades E
    Vaccine; 2006 Apr; 24(16):3224-31. PubMed ID: 16487631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.